{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:40:11Z","timestamp":1793896811689,"version":"4.8.0"},"reference-count":25,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:00:00Z","timestamp":1611187200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["IMI JU # 115011"],"award-info":[{"award-number":["IMI JU # 115011"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012147","name":"Royal Brompton and Harefield NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012147","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CERCA Programme, Generalitat de Catalunya"},{"name":"NIHR Respiratory Biomedical Research Unit"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2020,10,20]]},"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The Daily-PROactive and Clinical visit-PROactive Physical Activity (D-PPAC and C-PPAC) instruments in chronic obstructive pulmonary disease (COPD) combines questionnaire with activity monitor data to measure patients\u2019 experience of physical activity. Their amount, difficulty and total scores range from 0 (worst) to 100 (best) but require further psychometric evaluation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To test reliability, validity and responsiveness, and to define minimal important difference (MID), of the D-PPAC and C-PPAC instruments, in a large population of patients with stable COPD from diverse severities, settings and countries.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We used data from seven randomised controlled trials to evaluate D-PPAC and C-PPAC internal consistency and construct validity by sex, age groups, COPD severity, country and language as well as responsiveness to interventions, ability to detect change and MID.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We included 1324 patients (mean (SD) age 66 (8) years, forced expiratory volume in 1 s 55 (17)% predicted). Scores covered almost the full range from 0 to 100, showed strong internal consistency after stratification and correlated as a priori hypothesised with dyspnoea, health-related quality of life and exercise capacity. Difficulty scores improved after pharmacological treatment and pulmonary rehabilitation, while amount scores improved after behavioural physical activity interventions. All scores were responsive to changes in self-reported physical activity experience (both worsening and improvement) and to the occurrence of COPD exacerbations during follow-up. The MID was estimated to 6 for amount and difficulty scores and 4 for total score.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The D-PPAC and C-PPAC instruments are reliable and valid across diverse COPD populations and responsive to pharmacological and non-pharmacological interventions and changes in clinically relevant variables.<\/jats:p><\/jats:sec>","DOI":"10.1136\/thoraxjnl-2020-214554","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T18:32:55Z","timestamp":1611253975000},"page":"228-238","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":40,"title":["Validity and responsiveness of the Daily- and Clinical visit-PROactive Physical Activity in COPD (D-PPAC and C-PPAC) instruments"],"prefix":"10.1136","volume":"76","clinical-trial-number":[{"clinical-trial-number":"nct02424344","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02437994","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02158065","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02085161","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02189577","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01897298","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02424344","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02437994","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02158065","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02085161","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02189577","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01897298","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7097-4586","authenticated-orcid":false,"given":"Judith","family":"Garcia-Aymerich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milo A","family":"Puhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solange","family":"Corriol-Rohou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heleen","family":"Demeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Dobbels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damijan","family":"Erzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Frei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5149-2015","authenticated-orcid":false,"given":"Elena","family":"Gimeno-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3235-0454","authenticated-orcid":false,"given":"Nicholas S","family":"Hopkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Ivanoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zafeiris","family":"Louvaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael I","family":"Polkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto A","family":"Rabinovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Scuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie","family":"Tabberer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Vogiatzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Troosters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,1,21]]},"reference":[{"key":"2024092104101020000_76.3.228.1","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-12-33"},{"key":"2024092104101020000_76.3.228.2","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2013-204763"},{"key":"2024092104101020000_76.3.228.3","first-page":"1","article-title":"Experiences of living and dying with COPD: a systematic review and synthesis of the qualitative empirical literature","volume":"12","author":"Giacomini","year":"2012","journal-title":"Ont Health Technol Assess Ser"},{"key":"2024092104101020000_76.3.228.4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/BF03404889","article-title":"Importance of frequency, intensity, time and type (FITT) in physical activity assessment for epidemiological research","volume":"102","author":"Barisic","year":"2011","journal-title":"Can J Public Health"},{"key":"2024092104101020000_76.3.228.5","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.06.00064105"},{"key":"2024092104101020000_76.3.228.6","first-page":"242","article-title":"Development and testing of the pulmonary functional status and dyspnea questionnaire (PFSDQ)","volume":"23","author":"Lareau","year":"1994","journal-title":"Heart Lung"},{"key":"2024092104101020000_76.3.228.7","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/145.6.1321"},{"key":"2024092104101020000_76.3.228.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2006.07.010"},{"key":"2024092104101020000_76.3.228.9","doi-asserted-by":"publisher","DOI":"10.1016\/S1836-9553(12)70110-8"},{"key":"2024092104101020000_76.3.228.10","unstructured":"US Department of Health and Human Services Food and Drug Administration . Guidance for industry. patient-reported outcomes measures: use in medical product development to support labeling claims guidance for industry., 2009. Available: www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM193282.pdf [Accessed 27 Oct 2019]."},{"key":"2024092104101020000_76.3.228.11","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00183014"},{"key":"2024092104101020000_76.3.228.12","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00004814"},{"key":"2024092104101020000_76.3.228.13","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.2147\/COPD.S143488","article-title":"Activate: the effect of aclidinium\/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD","volume":"12","author":"Watz","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024092104101020000_76.3.228.14","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00679-2016"},{"key":"2024092104101020000_76.3.228.15","article-title":"Correlation between quadriceps strength and five exercise tests in subjects with chronic obstructive pulmonary disease (COPD) [abstract]","volume":"44","author":"Harvey-Dunstan","year":"2014","journal-title":"Eur Respir J"},{"key":"2024092104101020000_76.3.228.16","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2016-209026"},{"key":"2024092104101020000_76.3.228.17","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1164\/rccm.201706-1288OC","article-title":"Effect of bronchodilation, exercise training, and behavior modification on symptoms and physical activity in chronic obstructive pulmonary disease","volume":"198","author":"Troosters","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2024092104101020000_76.3.228.18","article-title":"Efficacy and safety of extrafine glycopyrronium bromide pMDI (CHF 5259) in COPD patients [abstract]","volume":"48","author":"Hajol","year":"2016","journal-title":"Eur Respir J"},{"key":"2024092104101020000_76.3.228.19","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00063-2018"},{"key":"2024092104101020000_76.3.228.20","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.04.00014304"},{"key":"2024092104101020000_76.3.228.21","unstructured":"EMA . Committee for medicinal products for human use (EMA). biomarkers qualification: guidance to applicants, 2008. Available: www.ema.europa.eu\/ema\/index.jsp?curl=pages\/regulation\/general\/general_content_000043.jsp [Accessed 27 Oct 2019]."},{"key":"2024092104101020000_76.3.228.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.03.012"},{"key":"2024092104101020000_76.3.228.23","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3390\/jcm8030340","article-title":"\"Can do\" versus \"do do\": a novel concept to better understand physical functioning in patients with chronic obstructive pulmonary disease","volume":"8","author":"Koolen","year":"2019","journal-title":"J Clin Med"},{"key":"2024092104101020000_76.3.228.24","doi-asserted-by":"publisher","DOI":"10.1097\/HCR.0b013e3181e175f2"},{"key":"2024092104101020000_76.3.228.25","unstructured":"European Medicines Agency . Qualification opinion on proactive in COPD. Available: https:\/\/www.ema.europa.eu\/en\/documents\/regulatory-procedural-guideline\/qualification-opinion-proactive-chronic-obstructive-pulmonary-disease-copd_en.pdf [Accessed 27 Oct 2019]."}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thoraxjnl-2020-214554","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T11:11:39Z","timestamp":1726917099000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thoraxjnl-2020-214554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,21]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,2,16]]},"published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.1136\/thoraxjnl-2020-214554"],"URL":"https:\/\/doi.org\/10.1136\/thoraxjnl-2020-214554","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,21]]}}}